- Medical Devices
- Thursday, 19 Oct 2023
US Orthotic Aids Market is expected to reach US$ 2,294.39 million by 2028
Braces to Dominate US Orthotic Aids Market Based on Product Type
According to our new research study on "US Orthotic Aids Market Forecast to 2028 – US Analysis – by Product Type, Application, Type of Supplier, and Distribution Channel," the orthotic aids market size was valued at US$ 1,494.55 million in 2022 and is projected to reach US$ 2,294.39 million by 2028. It is estimated to register a CAGR of 6.3% during 2022–2028.
The US orthotic aids market, by product type, is segmented into body belts, braces, and others. In 2022, the braces segment held the largest share, and it is expected to record the fastest CAGR during 2022–2028. Based on application, the orthotic aids market is classified into ligament injury repair, preventive care, osteoarthritis, compression therapy, and others. In 2022, the ligament injury repair segment held the largest market share. It is further expected to register the highest CAGR during 2022–2028. Based on the type of supplier, the orthotic aids market is segmented into branded and unbranded. In 2022, the branded segment held a larger market share. Further, the unbranded segment is expected to record a faster CAGR during 2022–2028. Based on distribution channel, the orthotic aids market is classified into online and offline. In 2022, the offline segment held a larger market share, and it is expected to record a higher CAGR during 2022–2028.
To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00030204
New Product Launches and Approvals
The US orthopedic aids market is continuously developing at a substantial rate due to the burgeoning demand for orthotic aids from a large population, which also leads to an increase in new product developments and launches along with approvals. Orthotic aids market players invest in R&D activities to ensure the revolution and development of effective products. In February 2021, Breg Inc, a leading manufacturer of knee, hip, elbow, spine, foot, and ankle braces, announced the launch of Pinnacle and Ascend lines of spinal orthoses. With this product, Breg Inc. intended to elevate spinal care through more comfortable braces that encourage treatment adherence and promote healing. In May 2020, Össur, a developer and manufacturer of bracing, compression therapy, prosthetics, and other orthopedic products announced the launch of Unloader One X, the most recent model of its Unloader One knee braces. Thus, new product launches and approvals by key market players is likely drive the growth of market
Ossur hf, Ottobock SE & Co KGaA, Thuasne SAS, Fillauer LLC, Lohmann & Rauscher GmbH & Co KG, DeRoyal Industries Inc, Hanger Inc, Steeper Group Holdings Ltd, Breg Inc, and DJO LLC are among the leading companies operating in the US orthotic aids market.
Contact Us
Contact Us: The Insight Partners
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Related Industry Updates
Europe Cardiovascular Devices Market to Witness an Outstanding Growth During 2020 With Top Key Players are Medtronic,Boston Scientific Corporation,Abbott,Biosense Webster, Inc. (Johnson and Johnson),General Electric Company,Koninklijke Philips N.V,Siemens AG,,BD,B. Braun Melsungen AG,Edwards Lifesciences Corporation.
Feb 10, 2021
KC Wearable Announces SMART Helmet is being used in 35 Countries Globally to Help tackle COVID-19 and End Lockdowns
Jun 16, 2020
Root Canal Antibacterium Market Trends, SWOT Analysis, Strategies, Industry Challenges
Feb 16, 2021
Wound Drainage Systems Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Cook, Degania Silicone Ltd., Poly Medicure Limited
Apr 15, 2021
Adjustable Pipettes Market Growth, Trends, and Forecast 2028
Mar 22, 2023
In-Vitro Diagnostic Market is expected to reach US$ 1,12,103.51 million by 2030
Sep 18, 2023
Global Pancreatic Cancer Therapy Market Business Opportunity to 2027 – Top Key Player Eli Lilly and Company, F. Hoffmann-La Roche AG, Celgene Corporation, Amgen Inc., Novartis AG
Apr 01, 2021